Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Normal Upper Extremity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01861054
What this trial is testing

Pilot Study to Evaluate Safety & Biological Effects of Orally Administered Reparixin in Early Breast Cancer

Who this might be right for
Breast Cancer
Dompé Farmaceutici S.p.A 20
Large-scale testing (Phase 3)Study completedNCT02511405
What this trial is testing

A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE)

Who this might be right for
Glioblastoma
Vascular Biogenics Ltd. operating as VBL Therapeutics 252
Testing effectiveness (Phase 2)UnknownNCT06152822
What this trial is testing

Pyrotinib Combined With Capecitabine and Bevacizumab for Patients With HER2 Positive Breast Cancer and Brain Metastases

Who this might be right for
Breast Cancer With Brain Metastases
Tongji Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT00210028
What this trial is testing

Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Institut Claudius Regaud 40
Not applicableStudy completedNCT01427166
What this trial is testing

Non-Invasive Imaging for Cording in Breast Cancer Patients

Who this might be right for
Breast Cancer
Massachusetts General Hospital 5
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06843681
What this trial is testing

Trastuzumab Plus Taxane Neoadjuvant Therapy for HER2-Positive Breast Ductal Carcinoma In Situ (DCIS) : A Phase II Study

Who this might be right for
Breast Carcinoma in Situ
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 54
Testing effectiveness (Phase 2)UnknownNCT04822805
What this trial is testing

Anlotinib in the Treatment of Recurrent High-grade Glioma

Who this might be right for
Recurrent High-grade Glioma
First People's Hospital of Hangzhou 27
Testing effectiveness (Phase 2)Looking for participantsNCT06647901
What this trial is testing

Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study

Who this might be right for
Giant Cell Tumor of Bone
Tang Xiaodong 45
Large-scale testing (Phase 3)Active Not RecruitingNCT04088396
What this trial is testing

Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Eli Lilly and Company 58
Early research (Phase 1)Ended earlyNCT01984255
What this trial is testing

A Two-arm, Single Center Phase 1b Trial of Bavituximab Plus Ipilimumab in Advanced Melanoma Patients

Who this might be right for
Melanoma
University of Texas Southwestern Medical Center 3
Not applicableStudy completedNCT02218385
What this trial is testing

ForeCYTE Breast Aspirator for Sample Collection and Cytological Testing of Nipple Aspirate Fluid

Who this might be right for
Breast Neoplasms
Atossa Therapeutics, Inc. 52
Testing effectiveness (Phase 2)WithdrawnNCT04909515
What this trial is testing

Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GMCSF) and Isotretinoin for Consolidation of Patients With High-Risk Neuroblastoma in First Remission.

Who this might be right for
Neuroblastoma
Y-mAbs Therapeutics
Testing effectiveness (Phase 2)Study completedNCT00811135
What this trial is testing

Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab) and Xeloda (Capecitabine) in Patients With HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 88
Not applicableNot Yet RecruitingNCT07809698
What this trial is testing

CT-AI Breast Cancer Opportunistic Screening Health Examination Study

Who this might be right for
Breast Neoplasms
The First Affiliated Hospital with Nanjing Medical University 30,000
Post-approval studies (Phase 4)Study completedNCT02550106
What this trial is testing

Omalizumab in Chronic Spontaneous Urticaria Patients Non Responding to Initial Standard antihistaminE Treatment

Who this might be right for
CHRONIC SPONTANEOUS URTICARIA
Novartis Pharmaceuticals 136
Testing effectiveness (Phase 2)Study completedNCT01554943
What this trial is testing

Late Cardiac Evaluation of the Three Arm Belgian Trial Involving Node-positive Early Breast Cancer Patients

Who this might be right for
Breast Cancer
Jules Bordet Institute 73
Testing effectiveness (Phase 2)Study completedNCT02114658
What this trial is testing

Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients

Who this might be right for
Thyroid Carcinoma
Bayer 18
Not applicableStudy completedNCT05371444
What this trial is testing

Control of Degrees of Freedom Post-stroke for the Recovery of the Upper Limb

Who this might be right for
Stroke
University of Chile 45
Testing effectiveness (Phase 2)UnknownNCT05265793
What this trial is testing

Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or Carcinosarcoma

Who this might be right for
PD-1 ImmunotherapyVEGFR-TKISarcomatoid Carcinoma+1 more
Fudan University 45
Large-scale testing (Phase 3)Study completedNCT04171414
What this trial is testing

Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Celltrion 62
Next Page